|
ABOUT COMPANY
Atossa Therapeutics, Inc., a clinical-stage biopharmaceutical company, discovers and develops drugs in the areas of oncology and infectious diseases. The company is headquartered in Seattle, Washington.
|
EARNINGS
Gross Profit (TTM): 0
Market Capitalization: 202598000
Operating Margin (TTM): 0
PE Ratio: None
PEG Ratio: 0
Profit Margin: 0
Revenue Per Share (TTM): 0
Revenue (TTM): 0
Quarterly Earnings Growth YOY: 0
Quarterly Revenue Growth YOY: 0
Trailing PE: -
|
DIVIDENDS
Diluted EPS (TTM): -0.31
Dividend Date: 2018-04-20
Dividend Per Share: None
Dividend Yield: 0%
EBITDA: -16713626
ExDividend Date: None
Forward Annual Dividend Rate:
Forward Annual Dividend Yield:
|